The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin

American Journal of Hematology

Volumn 63, Issue 3, 2000, Pages 156-158

  Sandler, S Gerald ^a,c   Novak, Sharon C ^a   Roland, Barbara ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Dominion   (United States)

^c GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Anti D; Immune globulin; Immune thrombocytopenic purpura; Intravenous; Rh immune globulin

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; RHESUS D ANTIBODY;

ARTICLE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT OUTCOME; UNITED STATES;

DATA COLLECTION; DRUG COSTS; HOSPITALS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC; RECOMBINANT PROTEINS; UNITED STATES;

EID: 0033997175     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200003)63:3<156::AID-AJH9>3.0.CO;2-4     Document Type: Article

References (10)

1. Bussel JB, Novoa M, Shine E, Woloski BMR. In patients with ITP, does 75 μg/kg of IV anti-D increase the platelet count faster than 50 μg/kg? Blood 1997;90(Suppl 1):82b. (Abstract).
2. Zunich KM, Harkonen SW, Woloski M, Kingsbury L. Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpura. Lancet 1995;346:1363.
3. Blanchette V, Imbach P, Andrew M, Adams M, McMillian J, Wang E, Milner R, All K, Barnard D, Chan KW, Esseltine D, deVeber B, Israels S, Kohrinsky N, Luke B. Randomized trials of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-708.
4. Rodeghiero F, Schiavotto, Castaman G, Vespignani M, Ruggeri M, Dini C. Follow-up study of 49 patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins. Haematologica 1992;77:248-252.
5. Blanchette V, Semple JW, Freedman JJL. Intravenous immunoglobulin and Rh immunoglobulin as immunomodulators of autoimmunity to blood elements. In: Silberstein LE, editor. Autoimmune disorders of blood. Bethesda: American Association of Blood Banks; 1996. p 61.
6. Andrew M, Blanchette VS, Adams M, Ali K, Banard D, Chan KW, DeVeber LB, Esseltine D, Israels S, Korbrinsky N, Luke B, Milner RA, Woloski BMR, Vegh P. A multicenter study of the treatment of childhood idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992;120:522-527.
7. Bussel J, Pham LC. Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature. Vox Sang 1987;52:206-211.
8. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. NEJM 1982;306:1254-1258.
9. Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997;89:2689-2700.
10. Simpson K, Coughlin CM, Eron J, Bussel JB. Idiopathic thrombocytopenic purpura: treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy. Semin Hematol 1998;35:58-64.